Global Gene Therapy Drugs Supply, Demand and Key Producers, 2023-2029

Page: 109

Published Date: 05 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Gene Therapy Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Gene Therapy Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gene Therapy Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gene Therapy Drugs total market, 2018-2029, (USD Million)
Global Gene Therapy Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene Therapy Drugs total market, key domestic companies and share, (USD Million)
Global Gene Therapy Drugs revenue by player and market share 2018-2023, (USD Million)
Global Gene Therapy Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Gene Therapy Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Gene Therapy Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical，Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio and Nightstar Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Gene Therapy Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Gene Therapy Drugs Market, Segmentation by Type
Neuromuscular Disease
Genetic Disease
Other

Global Gene Therapy Drugs Market, Segmentation by Application
Hospital
Pharmacy

Companies Profiled:
F. Hoffmann-La Roche AG
Novartis International AG
Gilead Sciences, Inc.
Ultragenyx Pharmaceutical，Inc.
Applied Genetic Technologies Corp
Audentes Therapeutics
BioMarin Pharmaceutical
Bluebird Bio
Nightstar Therapeutics
Sangamo Therapeutics
Spark Therapeutics
uniQure
VBL Therapeutics
Voyager Therapeutics

Key Questions Answered
1. How big is the global Gene Therapy Drugs market?
2. What is the demand of the global Gene Therapy Drugs market?
3. What is the year over year growth of the global Gene Therapy Drugs market?
4. What is the total value of the global Gene Therapy Drugs market?
5. Who are the major players in the global Gene Therapy Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Gene Therapy Drugs Introduction
    1.2 World Gene Therapy Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Gene Therapy Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Gene Therapy Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Gene Therapy Drugs Market Size (2018-2029)
        1.3.3 China Gene Therapy Drugs Market Size (2018-2029)
        1.3.4 Europe Gene Therapy Drugs Market Size (2018-2029)
        1.3.5 Japan Gene Therapy Drugs Market Size (2018-2029)
        1.3.6 South Korea Gene Therapy Drugs Market Size (2018-2029)
        1.3.7 ASEAN Gene Therapy Drugs Market Size (2018-2029)
        1.3.8 India Gene Therapy Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gene Therapy Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gene Therapy Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Gene Therapy Drugs Consumption Value (2018-2029)
    2.2 World Gene Therapy Drugs Consumption Value by Region
        2.2.1 World Gene Therapy Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Gene Therapy Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Gene Therapy Drugs Consumption Value (2018-2029)
    2.4 China Gene Therapy Drugs Consumption Value (2018-2029)
    2.5 Europe Gene Therapy Drugs Consumption Value (2018-2029)
    2.6 Japan Gene Therapy Drugs Consumption Value (2018-2029)
    2.7 South Korea Gene Therapy Drugs Consumption Value (2018-2029)
    2.8 ASEAN Gene Therapy Drugs Consumption Value (2018-2029)
    2.9 India Gene Therapy Drugs Consumption Value (2018-2029)

3 World Gene Therapy Drugs Companies Competitive Analysis
    3.1 World Gene Therapy Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Gene Therapy Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Gene Therapy Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Gene Therapy Drugs in 2022
    3.3 Gene Therapy Drugs Company Evaluation Quadrant
    3.4 Gene Therapy Drugs Market: Overall Company Footprint Analysis
        3.4.1 Gene Therapy Drugs Market: Region Footprint
        3.4.2 Gene Therapy Drugs Market: Company Product Type Footprint
        3.4.3 Gene Therapy Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Gene Therapy Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Gene Therapy Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Gene Therapy Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Gene Therapy Drugs Consumption Value Comparison
        4.2.1 United States VS China: Gene Therapy Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Gene Therapy Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Gene Therapy Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Gene Therapy Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Gene Therapy Drugs Revenue, (2018-2023)
    4.4 China Based Companies Gene Therapy Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Gene Therapy Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Gene Therapy Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Gene Therapy Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Gene Therapy Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Gene Therapy Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Gene Therapy Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Neuromuscular Disease
        5.2.2 Genetic Disease
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Gene Therapy Drugs Market Size by Type (2018-2023)
        5.3.2 World Gene Therapy Drugs Market Size by Type (2024-2029)
        5.3.3 World Gene Therapy Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Gene Therapy Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Pharmacy
    6.3 Market Segment by Application
        6.3.1 World Gene Therapy Drugs Market Size by Application (2018-2023)
        6.3.2 World Gene Therapy Drugs Market Size by Application (2024-2029)
        6.3.3 World Gene Therapy Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 F. Hoffmann-La Roche AG
        7.1.1 F. Hoffmann-La Roche AG Details
        7.1.2 F. Hoffmann-La Roche AG Major Business
        7.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Product and Services
        7.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 F. Hoffmann-La Roche AG Recent Developments/Updates
        7.1.6 F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
    7.2 Novartis International AG
        7.2.1 Novartis International AG Details
        7.2.2 Novartis International AG Major Business
        7.2.3 Novartis International AG Gene Therapy Drugs Product and Services
        7.2.4 Novartis International AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis International AG Recent Developments/Updates
        7.2.6 Novartis International AG Competitive Strengths & Weaknesses
    7.3 Gilead Sciences, Inc.
        7.3.1 Gilead Sciences, Inc. Details
        7.3.2 Gilead Sciences, Inc. Major Business
        7.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Product and Services
        7.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Gilead Sciences, Inc. Recent Developments/Updates
        7.3.6 Gilead Sciences, Inc. Competitive Strengths & Weaknesses
    7.4 Ultragenyx Pharmaceutical，Inc.
        7.4.1 Ultragenyx Pharmaceutical，Inc. Details
        7.4.2 Ultragenyx Pharmaceutical，Inc. Major Business
        7.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product and Services
        7.4.4 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Ultragenyx Pharmaceutical，Inc. Recent Developments/Updates
        7.4.6 Ultragenyx Pharmaceutical，Inc. Competitive Strengths & Weaknesses
    7.5 Applied Genetic Technologies Corp
        7.5.1 Applied Genetic Technologies Corp Details
        7.5.2 Applied Genetic Technologies Corp Major Business
        7.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Product and Services
        7.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Applied Genetic Technologies Corp Recent Developments/Updates
        7.5.6 Applied Genetic Technologies Corp Competitive Strengths & Weaknesses
    7.6 Audentes Therapeutics
        7.6.1 Audentes Therapeutics Details
        7.6.2 Audentes Therapeutics Major Business
        7.6.3 Audentes Therapeutics Gene Therapy Drugs Product and Services
        7.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Audentes Therapeutics Recent Developments/Updates
        7.6.6 Audentes Therapeutics Competitive Strengths & Weaknesses
    7.7 BioMarin Pharmaceutical
        7.7.1 BioMarin Pharmaceutical Details
        7.7.2 BioMarin Pharmaceutical Major Business
        7.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Product and Services
        7.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 BioMarin Pharmaceutical Recent Developments/Updates
        7.7.6 BioMarin Pharmaceutical Competitive Strengths & Weaknesses
    7.8 Bluebird Bio
        7.8.1 Bluebird Bio Details
        7.8.2 Bluebird Bio Major Business
        7.8.3 Bluebird Bio Gene Therapy Drugs Product and Services
        7.8.4 Bluebird Bio Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Bluebird Bio Recent Developments/Updates
        7.8.6 Bluebird Bio Competitive Strengths & Weaknesses
    7.9 Nightstar Therapeutics
        7.9.1 Nightstar Therapeutics Details
        7.9.2 Nightstar Therapeutics Major Business
        7.9.3 Nightstar Therapeutics Gene Therapy Drugs Product and Services
        7.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Nightstar Therapeutics Recent Developments/Updates
        7.9.6 Nightstar Therapeutics Competitive Strengths & Weaknesses
    7.10 Sangamo Therapeutics
        7.10.1 Sangamo Therapeutics Details
        7.10.2 Sangamo Therapeutics Major Business
        7.10.3 Sangamo Therapeutics Gene Therapy Drugs Product and Services
        7.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Sangamo Therapeutics Recent Developments/Updates
        7.10.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
    7.11 Spark Therapeutics
        7.11.1 Spark Therapeutics Details
        7.11.2 Spark Therapeutics Major Business
        7.11.3 Spark Therapeutics Gene Therapy Drugs Product and Services
        7.11.4 Spark Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Spark Therapeutics Recent Developments/Updates
        7.11.6 Spark Therapeutics Competitive Strengths & Weaknesses
    7.12 uniQure
        7.12.1 uniQure Details
        7.12.2 uniQure Major Business
        7.12.3 uniQure Gene Therapy Drugs Product and Services
        7.12.4 uniQure Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 uniQure Recent Developments/Updates
        7.12.6 uniQure Competitive Strengths & Weaknesses
    7.13 VBL Therapeutics
        7.13.1 VBL Therapeutics Details
        7.13.2 VBL Therapeutics Major Business
        7.13.3 VBL Therapeutics Gene Therapy Drugs Product and Services
        7.13.4 VBL Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 VBL Therapeutics Recent Developments/Updates
        7.13.6 VBL Therapeutics Competitive Strengths & Weaknesses
    7.14 Voyager Therapeutics
        7.14.1 Voyager Therapeutics Details
        7.14.2 Voyager Therapeutics Major Business
        7.14.3 Voyager Therapeutics Gene Therapy Drugs Product and Services
        7.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Voyager Therapeutics Recent Developments/Updates
        7.14.6 Voyager Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gene Therapy Drugs Industry Chain
    8.2 Gene Therapy Drugs Upstream Analysis
    8.3 Gene Therapy Drugs Midstream Analysis
    8.4 Gene Therapy Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gene Therapy Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Gene Therapy Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Gene Therapy Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Gene Therapy Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Gene Therapy Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Gene Therapy Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Gene Therapy Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Gene Therapy Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Gene Therapy Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Gene Therapy Drugs Players in 2022
    Table 12. World Gene Therapy Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Gene Therapy Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Gene Therapy Drugs Player
    Table 15. Gene Therapy Drugs Market: Company Product Type Footprint
    Table 16. Gene Therapy Drugs Market: Company Product Application Footprint
    Table 17. Gene Therapy Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Gene Therapy Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Gene Therapy Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Gene Therapy Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Gene Therapy Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Gene Therapy Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Gene Therapy Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Gene Therapy Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Gene Therapy Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Gene Therapy Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Gene Therapy Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Gene Therapy Drugs Revenue Market Share (2018-2023)
    Table 29. World Gene Therapy Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Gene Therapy Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Gene Therapy Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Gene Therapy Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Gene Therapy Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Gene Therapy Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. F. Hoffmann-La Roche AG Basic Information, Area Served and Competitors
    Table 36. F. Hoffmann-La Roche AG Major Business
    Table 37. F. Hoffmann-La Roche AG Gene Therapy Drugs Product and Services
    Table 38. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. F. Hoffmann-La Roche AG Recent Developments/Updates
    Table 40. F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
    Table 41. Novartis International AG Basic Information, Area Served and Competitors
    Table 42. Novartis International AG Major Business
    Table 43. Novartis International AG Gene Therapy Drugs Product and Services
    Table 44. Novartis International AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Novartis International AG Recent Developments/Updates
    Table 46. Novartis International AG Competitive Strengths & Weaknesses
    Table 47. Gilead Sciences, Inc. Basic Information, Area Served and Competitors
    Table 48. Gilead Sciences, Inc. Major Business
    Table 49. Gilead Sciences, Inc. Gene Therapy Drugs Product and Services
    Table 50. Gilead Sciences, Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Gilead Sciences, Inc. Recent Developments/Updates
    Table 52. Gilead Sciences, Inc. Competitive Strengths & Weaknesses
    Table 53. Ultragenyx Pharmaceutical，Inc. Basic Information, Area Served and Competitors
    Table 54. Ultragenyx Pharmaceutical，Inc. Major Business
    Table 55. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product and Services
    Table 56. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Ultragenyx Pharmaceutical，Inc. Recent Developments/Updates
    Table 58. Ultragenyx Pharmaceutical，Inc. Competitive Strengths & Weaknesses
    Table 59. Applied Genetic Technologies Corp Basic Information, Area Served and Competitors
    Table 60. Applied Genetic Technologies Corp Major Business
    Table 61. Applied Genetic Technologies Corp Gene Therapy Drugs Product and Services
    Table 62. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Applied Genetic Technologies Corp Recent Developments/Updates
    Table 64. Applied Genetic Technologies Corp Competitive Strengths & Weaknesses
    Table 65. Audentes Therapeutics Basic Information, Area Served and Competitors
    Table 66. Audentes Therapeutics Major Business
    Table 67. Audentes Therapeutics Gene Therapy Drugs Product and Services
    Table 68. Audentes Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Audentes Therapeutics Recent Developments/Updates
    Table 70. Audentes Therapeutics Competitive Strengths & Weaknesses
    Table 71. BioMarin Pharmaceutical Basic Information, Area Served and Competitors
    Table 72. BioMarin Pharmaceutical Major Business
    Table 73. BioMarin Pharmaceutical Gene Therapy Drugs Product and Services
    Table 74. BioMarin Pharmaceutical Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. BioMarin Pharmaceutical Recent Developments/Updates
    Table 76. BioMarin Pharmaceutical Competitive Strengths & Weaknesses
    Table 77. Bluebird Bio Basic Information, Area Served and Competitors
    Table 78. Bluebird Bio Major Business
    Table 79. Bluebird Bio Gene Therapy Drugs Product and Services
    Table 80. Bluebird Bio Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Bluebird Bio Recent Developments/Updates
    Table 82. Bluebird Bio Competitive Strengths & Weaknesses
    Table 83. Nightstar Therapeutics Basic Information, Area Served and Competitors
    Table 84. Nightstar Therapeutics Major Business
    Table 85. Nightstar Therapeutics Gene Therapy Drugs Product and Services
    Table 86. Nightstar Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Nightstar Therapeutics Recent Developments/Updates
    Table 88. Nightstar Therapeutics Competitive Strengths & Weaknesses
    Table 89. Sangamo Therapeutics Basic Information, Area Served and Competitors
    Table 90. Sangamo Therapeutics Major Business
    Table 91. Sangamo Therapeutics Gene Therapy Drugs Product and Services
    Table 92. Sangamo Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Sangamo Therapeutics Recent Developments/Updates
    Table 94. Sangamo Therapeutics Competitive Strengths & Weaknesses
    Table 95. Spark Therapeutics Basic Information, Area Served and Competitors
    Table 96. Spark Therapeutics Major Business
    Table 97. Spark Therapeutics Gene Therapy Drugs Product and Services
    Table 98. Spark Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Spark Therapeutics Recent Developments/Updates
    Table 100. Spark Therapeutics Competitive Strengths & Weaknesses
    Table 101. uniQure Basic Information, Area Served and Competitors
    Table 102. uniQure Major Business
    Table 103. uniQure Gene Therapy Drugs Product and Services
    Table 104. uniQure Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. uniQure Recent Developments/Updates
    Table 106. uniQure Competitive Strengths & Weaknesses
    Table 107. VBL Therapeutics Basic Information, Area Served and Competitors
    Table 108. VBL Therapeutics Major Business
    Table 109. VBL Therapeutics Gene Therapy Drugs Product and Services
    Table 110. VBL Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. VBL Therapeutics Recent Developments/Updates
    Table 112. Voyager Therapeutics Basic Information, Area Served and Competitors
    Table 113. Voyager Therapeutics Major Business
    Table 114. Voyager Therapeutics Gene Therapy Drugs Product and Services
    Table 115. Voyager Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Gene Therapy Drugs Upstream (Raw Materials)
    Table 117. Gene Therapy Drugs Typical Customers
List of Figure
    Figure 1. Gene Therapy Drugs Picture
    Figure 2. World Gene Therapy Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Gene Therapy Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Gene Therapy Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Gene Therapy Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Gene Therapy Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Gene Therapy Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Gene Therapy Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Gene Therapy Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Gene Therapy Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Gene Therapy Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Gene Therapy Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Gene Therapy Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Gene Therapy Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Gene Therapy Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Gene Therapy Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Gene Therapy Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Gene Therapy Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Gene Therapy Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Gene Therapy Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Gene Therapy Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Gene Therapy Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Gene Therapy Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy Drugs Markets in 2022
    Figure 27. United States VS China: Gene Therapy Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Gene Therapy Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Gene Therapy Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Gene Therapy Drugs Market Size Market Share by Type in 2022
    Figure 31. Neuromuscular Disease
    Figure 32. Genetic Disease
    Figure 33. Other
    Figure 34. World Gene Therapy Drugs Market Size Market Share by Type (2018-2029)
    Figure 35. World Gene Therapy Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Gene Therapy Drugs Market Size Market Share by Application in 2022
    Figure 37. Hospital
    Figure 38. Pharmacy
    Figure 39. Gene Therapy Drugs Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gene Therapy Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Gene Therapy Drugs

Viral Vector-Based Gene Therapy Drugs

Retrovirus-Based Gene Therapy Drugs

AAV Vector-Based Gene Therapy Drugs

AAV Gene Therapy Drugs

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>